vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and Rumble Inc. (RUM). Click either name above to swap in a different company.
Karyopharm Therapeutics Inc. is the larger business by last-quarter revenue ($34.1M vs $27.1M, roughly 1.3× Rumble Inc.). Rumble Inc. runs the higher net margin — -120.8% vs -299.9%, a 179.1% gap on every dollar of revenue. On growth, Karyopharm Therapeutics Inc. posted the faster year-over-year revenue change (11.6% vs -10.5%). Over the past eight quarters, Rumble Inc.'s revenue compounded faster (15.2% CAGR vs 1.4%).
Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".
KPTI vs RUM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $27.1M |
| Net Profit | $-102.2M | $-32.7M |
| Gross Margin | — | 5.5% |
| Operating Margin | -52.4% | -131.1% |
| Net Margin | -299.9% | -120.8% |
| Revenue YoY | 11.6% | -10.5% |
| Net Profit YoY | -232.0% | 86.2% |
| EPS (diluted) | $-7.02 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.1M | $27.1M | ||
| Q3 25 | $44.0M | $24.8M | ||
| Q2 25 | $37.9M | — | ||
| Q1 25 | $30.0M | $23.7M | ||
| Q4 24 | $30.5M | $30.2M | ||
| Q3 24 | $38.8M | $25.1M | ||
| Q2 24 | $42.8M | $22.5M | ||
| Q1 24 | $33.1M | $17.7M |
| Q4 25 | $-102.2M | $-32.7M | ||
| Q3 25 | $-33.1M | $-16.3M | ||
| Q2 25 | $-37.3M | — | ||
| Q1 25 | $-23.5M | $-2.7M | ||
| Q4 24 | $-30.8M | $-236.8M | ||
| Q3 24 | $-32.1M | $-31.5M | ||
| Q2 24 | $23.8M | $-26.8M | ||
| Q1 24 | $-37.4M | $-43.3M |
| Q4 25 | — | 5.5% | ||
| Q3 25 | — | -1.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -26.7% | ||
| Q4 24 | — | -14.2% | ||
| Q3 24 | — | -45.4% | ||
| Q2 24 | — | -58.8% | ||
| Q1 24 | — | -79.5% |
| Q4 25 | -52.4% | -131.1% | ||
| Q3 25 | -34.6% | -113.6% | ||
| Q2 25 | -64.3% | — | ||
| Q1 25 | -110.8% | -153.5% | ||
| Q4 24 | -102.4% | -80.1% | ||
| Q3 24 | -67.8% | -131.0% | ||
| Q2 24 | -65.7% | -172.7% | ||
| Q1 24 | -101.9% | -197.4% |
| Q4 25 | -299.9% | -120.8% | ||
| Q3 25 | -75.2% | -65.7% | ||
| Q2 25 | -98.2% | — | ||
| Q1 25 | -78.2% | -11.2% | ||
| Q4 24 | -100.8% | -783.2% | ||
| Q3 24 | -82.7% | -125.9% | ||
| Q2 24 | 55.6% | -119.2% | ||
| Q1 24 | -112.8% | -244.1% |
| Q4 25 | $-7.02 | $-0.13 | ||
| Q3 25 | $-3.82 | $-0.06 | ||
| Q2 25 | $-4.32 | — | ||
| Q1 25 | $-2.77 | $-0.01 | ||
| Q4 24 | $-2.33 | $-1.17 | ||
| Q3 24 | $-3.85 | $-0.15 | ||
| Q2 24 | $-2.97 | $-0.13 | ||
| Q1 24 | $-4.85 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | $237.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-292.9M | $274.8M |
| Total Assets | $108.4M | $336.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.5M | $237.9M | ||
| Q3 25 | $37.7M | $269.8M | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $38.8M | $301.3M | ||
| Q4 24 | $62.5M | $114.0M | ||
| Q3 24 | $72.8M | $132.0M | ||
| Q2 24 | $84.8M | $154.2M | ||
| Q1 24 | $30.6M | $183.8M |
| Q4 25 | $-292.9M | $274.8M | ||
| Q3 25 | $-269.3M | $302.2M | ||
| Q2 25 | $-238.9M | — | ||
| Q1 25 | $-205.9M | $339.6M | ||
| Q4 24 | $-186.0M | $-63.1M | ||
| Q3 24 | $-159.6M | $166.1M | ||
| Q2 24 | $-132.1M | $192.7M | ||
| Q1 24 | $-169.0M | $210.7M |
| Q4 25 | $108.4M | $336.8M | ||
| Q3 25 | $96.2M | $367.2M | ||
| Q2 25 | $104.9M | — | ||
| Q1 25 | $127.7M | $391.1M | ||
| Q4 24 | $164.4M | $195.3M | ||
| Q3 24 | $189.5M | $217.2M | ||
| Q2 24 | $214.0M | $243.2M | ||
| Q1 24 | $204.5M | $263.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-31.7M |
| FCF MarginFCF / Revenue | — | -117.2% |
| Capex IntensityCapex / Revenue | 0.0% | 8.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-70.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.8M | $-29.4M | ||
| Q3 25 | $-5.9M | $-10.6M | ||
| Q2 25 | $-18.7M | — | ||
| Q1 25 | $-39.0M | $-14.5M | ||
| Q4 24 | $-25.8M | $-12.4M | ||
| Q3 24 | $-19.5M | $-19.1M | ||
| Q2 24 | $-38.5M | $-21.7M | ||
| Q1 24 | $-43.7M | $-33.9M |
| Q4 25 | — | $-31.7M | ||
| Q3 25 | — | $-12.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-14.6M | ||
| Q4 24 | $-25.9M | $-12.4M | ||
| Q3 24 | — | $-19.9M | ||
| Q2 24 | — | $-23.1M | ||
| Q1 24 | $-43.9M | $-34.3M |
| Q4 25 | — | -117.2% | ||
| Q3 25 | — | -48.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -61.7% | ||
| Q4 24 | -84.7% | -40.9% | ||
| Q3 24 | — | -79.5% | ||
| Q2 24 | — | -102.8% | ||
| Q1 24 | -132.6% | -193.3% |
| Q4 25 | 0.0% | 8.5% | ||
| Q3 25 | 0.0% | 5.7% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.0% | 3.4% | ||
| Q2 24 | 0.0% | 6.1% | ||
| Q1 24 | 0.6% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.62× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
